Persistent Lyme Arthritis: Infection or Inflammatory Immune Response?

Persistent Lyme arthritis remains controversial
Could persistent antigens drive inflammation?
Or does persistent infection still play a role?

Persistent Lyme arthritis remains controversial because symptoms may continue despite treatment. Researchers have explored whether ongoing symptoms reflect residual inflammation, immune dysregulation, persistent antigens, persistent infection, or some combination of these mechanisms.

Borrelia burgdorferi peptidoglycan (PG(Bb)) fragments may contribute to inflammation during infection and in post-infectious Lyme arthritis. Researchers have increasingly focused on whether these persistent antigens could explain ongoing symptoms in some patients.

According to Jutras and colleagues, PG(Bb) fragments likely “contribute to inflammation during infection and in cases of post-infectious Lyme arthritis.” In a mouse study, the authors found “that PG(Bb) alone was sufficient to induce acute arthritis.”

Furthermore, Jutras and colleagues suggest that “immune responses to PG(Bb) and autoantigens may contribute to pathology, even after the infection itself has been cleared.” Varying disease severity in patients with Lyme arthritis may be due to differences in specific PG(Bb) immune responses, they claim.

Author’s note: Jutras and colleagues assume the infection has resolved. However, there is no reliable test proving a Lyme disease infection has fully cleared in every patient.

The debate over persistent Lyme arthritis often centers on whether symptoms are driven by ongoing inflammation, persistent bacterial antigens, immune dysregulation, persistent infection, or overlapping mechanisms.

Distinguishing active infection from persistent inflammation remains challenging because no single test reliably determines whether symptoms reflect active infection, residual immune activation, or both.

Jutras and colleagues raise the question: How can PG(Bb) material remain in the synovial environment for an extended period (weeks to months) after appropriate antibiotic treatment?

Three explanations for persistent Borrelia peptidoglycan antigens

1. PG material may be left behind after bacterial killing.
2. Macrophages may store PG in vesicles.
3. PG-containing immune complexes may accumulate in the synovial fluid.

To dampen the immune response to PG(Bb), Jutras and colleagues suggest using disease-modifying anti-rheumatic drugs, primarily hydroxychloroquine or methotrexate.

In addition, they recommend targeting innate immune responses with medications such as TNF or NF-κB inhibitors for selected patients with persistent inflammatory symptoms.

Researchers studying persistent Lyme disease mechanisms continue to debate whether inflammatory pathways alone explain persistent symptoms in all patients.

[bctt tweet=”Persistent Borrelia antigens may contribute to ongoing inflammation in Lyme arthritis, raising questions about immune activation and persistent infection.” username=”DrDanielCameron”]

Lastly, the authors found that Borrelia burgdorferi releases PG(Bb) fragments during growth, suggesting that PG(Bb) may play a broader role in Lyme disease pathogenesis beyond Lyme arthritis.

One must ask, however: Could an active Lyme infection be driving the persistent antigen PG(Bb)?

The authors did not propose the possibility that PG(Bb) material might result from persistent infection. If this possibility were considered, treatment approaches might differ from immune-modulating therapies alone.

FAQ

What is persistent Lyme arthritis?

Persistent Lyme arthritis describes ongoing joint symptoms that continue after standard treatment. Proposed explanations include persistent inflammation, immune dysregulation, residual bacterial antigens, and possibly persistent infection in selected cases.

Can Lyme arthritis continue after antibiotics?

Some patients report persistent symptoms after treatment. Researchers have proposed several explanations including immune activation, residual bacterial antigens, inflammatory pathways, and persistent infection in selected cases.

What is post-infectious Lyme arthritis?

Post-infectious Lyme arthritis describes persistent joint symptoms after treatment where researchers have proposed mechanisms including immune activation, residual bacterial antigens, and inflammatory pathways.

Can Lyme disease cause inflammation after treatment?

Persistent inflammatory symptoms have been reported after treatment. Researchers continue investigating whether symptoms arise from immune activation, residual antigens, persistent infection, or overlapping mechanisms.

What is Borrelia peptidoglycan?

Peptidoglycan is a structural component of Borrelia burgdorferi. Researchers have proposed that persistent fragments may contribute to inflammation even after treatment.

Clinical Perspective

The relationship between persistent Lyme arthritis, immune activation, and persistent infection remains debated. Studies involving PG(Bb) provide one explanation for ongoing inflammation, but they do not fully resolve whether persistent infection contributes in selected patients.

Clinical Takeaway

Persistent Lyme arthritis likely reflects multiple mechanisms rather than a single explanation. Residual antigens, inflammatory pathways, immune responses, and possible persistent infection remain active areas of investigation.

Related Articles

Lyme arthritis
Persistent Lyme disease overview
Persistent Lyme disease mechanisms
Post-treatment Lyme disease syndrome

References

1. Jutras BL, Lochhead RB, Kloos ZA, et al. Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis. Proc Natl Acad Sci U S A. 2019;116(27):13498-13507.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention